Scancell is a clinical stage biopharmaceutical company that leverages proprietary research to generate novel medicines for treating cancer and infectious diseases.
competitor of
Metrics
marketPRIVATE
msh_idUK:CO:SCANCELL
localegb
websitehttps://www.scancell.co.uk
source_ref221a9f20-86a5-4639-bc5c-9307508271ce
products_or_servicesVaccines and monoclonal antibodies targeting cancer and infectious diseases.